Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 242

    1.

    Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

    Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, Shaw PM, Smeds J, Skoog L, Wedrén S, Bergh J.

    Breast Cancer Res. 2005;7(6):R953-64. Epub 2005 Oct 3.

    PMID:
    16280042
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

    Bueno-de-Mesquita JM, van Harten WH, Retel VP, van't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, van de Vijver MJ, Linn SC.

    Lancet Oncol. 2007 Dec;8(12):1079-87. Epub 2007 Nov 26. Erratum in: Lancet Oncol. 2008 Jan;9(1):10.

    PMID:
    18042430
    [PubMed - indexed for MEDLINE]
    3.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

    PMID:
    16959170
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.

    PMID:
    17993229
    [PubMed - indexed for MEDLINE]
    5.

    Population-based molecular prognosis of breast cancer by transcriptional profiling.

    Ma Y, Qian Y, Wei L, Abraham J, Shi X, Castranova V, Harner EJ, Flynn DC, Guo L.

    Clin Cancer Res. 2007 Apr 1;13(7):2014-22.

    PMID:
    17404081
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.

    Nuyten DS, Hastie T, Chi JT, Chang HY, van de Vijver MJ.

    Eur J Cancer. 2008 Oct;44(15):2319-29. Epub 2008 Aug 18.

    PMID:
    18715778
    [PubMed - indexed for MEDLINE]
    7.

    Integrated gene expression profile predicts prognosis of breast cancer patients.

    Li LF, Xu XJ, Zhao Y, Liu ZB, Shen ZZ, Jin WR, Shao ZM.

    Breast Cancer Res Treat. 2009 Jan;113(2):231-7. Epub 2008 Feb 16.

    PMID:
    18278552
    [PubMed - indexed for MEDLINE]
    8.

    Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.

    Johansson P, Fohlin H, Arnesson LG, Dufmats M, Nordenskjöld K, Nordenskjöld B, Stål O; South-East Sweden Breast Cancer Study Group.

    Acta Oncol. 2009;48(4):504-13.

    PMID:
    19235568
    [PubMed - indexed for MEDLINE]
    9.

    Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

    Mook S, Schmidt MK, Rutgers EJ, van de Velde AO, Visser O, Rutgers SM, Armstrong N, van't Veer LJ, Ravdin PM.

    Lancet Oncol. 2009 Nov;10(11):1070-6. Epub 2009 Oct 2.

    PMID:
    19801202
    [PubMed - indexed for MEDLINE]
    10.

    Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.

    Tutt A, Wang A, Rowland C, Gillett C, Lau K, Chew K, Dai H, Kwok S, Ryder K, Shu H, Springall R, Cane P, McCallie B, Kam-Morgan L, Anderson S, Buerger H, Gray J, Bennington J, Esserman L, Hastie T, Broder S, Sninsky J, Brandt B, Waldman F.

    BMC Cancer. 2008 Nov 21;8:339.

    PMID:
    19025599
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    A gene-expression signature as a predictor of survival in breast cancer.

    van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R.

    N Engl J Med. 2002 Dec 19;347(25):1999-2009.

    PMID:
    12490681
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

    BMC Cancer. 2007 Apr 12;7:63.

    PMID:
    17430582
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.

    PMID:
    17850661
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

    Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F, Golouh R, Talantov D, Wang Y, Foekens JA.

    Breast Cancer Res Treat. 2009 Jul;116(2):303-9. Epub 2008 Sep 23.

    PMID:
    18821012
    [PubMed - indexed for MEDLINE]
    15.

    A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.

    Jézéquel P, Campone M, Roché H, Gouraud W, Charbonnel C, Ricolleau G, Magrangeas F, Minvielle S, Genève J, Martin AL, Bataille R, Campion L.

    Breast Cancer Res Treat. 2009 Aug;116(3):509-20. Epub 2008 Nov 20.

    PMID:
    19020972
    [PubMed - indexed for MEDLINE]
    16.

    Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

    Breast Cancer Res Treat. 2009 Jul;116(1):131-43. Epub 2008 Jul 31.

    PMID:
    18668363
    [PubMed - indexed for MEDLINE]
    17.

    Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.

    Kok M, Linn SC, Van Laar RK, Jansen MP, van den Berg TM, Delahaye LJ, Glas AM, Peterse JL, Hauptmann M, Foekens JA, Klijn JG, Wessels LF, Van't Veer LJ, Berns EM.

    Breast Cancer Res Treat. 2009 Jan;113(2):275-83. Epub 2008 Mar 4.

    PMID:
    18311582
    [PubMed - indexed for MEDLINE]
    18.

    Who should not receive adjuvant chemotherapy? International databases.

    Bergh J, Holmquist M.

    J Natl Cancer Inst Monogr. 2001;(30):103-8.

    PMID:
    11773301
    [PubMed - indexed for MEDLINE]
    19.

    Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer.

    Espinosa E, Sánchez-Navarro I, Gámez-Pozo A, Marin AP, Hardisson D, Madero R, Redondo A, Zamora P, San José Valiente B, Mendiola M, González Barón M, Fresno Vara JA.

    PLoS One. 2009 Jun 15;4(6):e5911.

    PMID:
    19547727
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

    Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ.

    Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7.

    PMID:
    16609019
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk